Tancer M E, Stein M B, Uhde T W
Section on Anxiety and Affective Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
Biol Psychiatry. 1993 Nov 1;34(9):591-5. doi: 10.1016/0006-3223(93)90150-c.
The growth hormone (GH) response to intravenous administration of clonidine hydrochloride (2 micrograms/kg) was assessed in 16 patients with DSM-III-R social phobia, 13 patients with DSM-III-R panic disorder, and 31 healthy controls. Compared to the healthy volunteers, both social phobic and panic-disorder patients had significantly blunted GH increments after clonidine. The social phobic patients demonstrated a similar degree of GH "blunting" to clonidine as did the patients with panic disorder.
